Journal Browser Advanced Search Help
Journal Browser Advanced search HELP
Korean J Nephrol. 2000 Jan;19(1):83-90. Korean. Original Article.
Song HY , Hwang JH , Roh HJ , Ryu DR , Yoo TH , Song YS , Kim JS , Noh HJ , Shin SK , Lee CH , Choi KH , Lee SK , Ha SK , Lee HY , Han DS .
Department of Internal Medicine, Yonsei University College of Medicine, Korea. khchoi6@yumc.yonsei.ac.kr
Division of Rheumatology, Yonsei University College of Medicine, Korea.
Division of Nephrology, Institute of Kidney Disease, Yonsei University College of Medicine, Korea.
Abstract

Lupus nephritis is a major cause of morbidity and mortality arising from systemic lupus erythematous. It is generally acknowledged that the presence of diffuse proliferative lupus nephritis(DPLN) is highly predictive of a poor prognosis in terms of renal and patient out- come on survival. The objective of this study was to evaluate the clinicopathologic characteristics, renal out- come according to therapeutic regimen, and prognostic factors of biopsy-proven diffuse proliferative lupus nephritis. Among the biopsy-proven lupus nephritis patients who were admitted to Yonsei University Medical Center from January 1986 to June 1997, 36 patents who were diagnosed DPLN by renal biopsy and treated for at least 6 months and regularly followed-up for at least 12 months were included. We retrospec-tively reviewed the medical recorders. Patients were treated with steroid regimen with or without cyclo-phosphamide. According to the therapeutic response, patients were divided into two groups : a therapeutic response group(n=24), and a therapeutic non-response group

Copyright © 2019. Korean Association of Medical Journal Editors.